Filip Peters | Source | CEO at Acorai
Filip Peters
Filip Peters leads Acorai, a medical technology company focused on advancing non-invasive solutions for heart health. With a deep commitment to innovation and accessibility, Filip has guided the company through significant clinical milestones and strategic collaborations with renowned institutions. His leadership is shaping a new approach to diagnostics and care in the field of heart failure management.
-
Acorai (https://acorai.com/)
CEO
-
Acorai raises $4.5M in seed for heart monitor trial
The $4.5 million in seed funding that Acorai AB recently raised will allow the company to continue its forward momentum in developing its technology to support the treatment of patients living with heart failure, Matthew Mace, co-founder and chief scientific officer told BioWorld. In practice, this means that with the funds the company will be able to meet its “projected timelines on the path toward regulatory approval in the U.S., focus on market entry and get the device into the hands of health care professionals sooner.”
Article
-
projected timelines on the path toward regulatory approval in the U.S., focus on market entry and get the device into the hands of health care professionals sooner.